186 related articles for article (PubMed ID: 32123937)
1. International Regensburg Center for Interventional Immunology (RCI) symposium on "Synthetic immunology and environment-adapted redirection of T cells", 17-18 July, 2019, Regensburg, Germany.
Beckhove P; Edinger M; Feuerer M; Gattinoni L; Abken H
Cancer Immunol Immunother; 2020 Apr; 69(4):677-682. PubMed ID: 32123937
[No Abstract] [Full Text] [Related]
2. Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases.
Chen Y; Sun J; Liu H; Yin G; Xie Q
J Immunol Res; 2019; 2019():5727516. PubMed ID: 32083141
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Tailoring of Regulatory T Cells Prior to Cell Therapy.
Baeten P; Hellings N; Broux B
Trends Mol Med; 2020 Nov; 26(11):1059-1060. PubMed ID: 32978063
[No Abstract] [Full Text] [Related]
4. Efficacy of regulatory T-cell immunotherapy: are inflammatory cytokines key determinants?
Bayry J; Lacroix-Desmazes S; Dasgupta S; Kazatchkine MD; Kaveri SV
Nat Rev Immunol; 2008 Jan; 8(1):1p following 86; author reply 1p following 86. PubMed ID: 18049489
[No Abstract] [Full Text] [Related]
5. Armed T cells with CAR for cancer immunotherapy.
Wei YQ
Sci China Life Sci; 2016 Apr; 59(4):331-2. PubMed ID: 27080712
[No Abstract] [Full Text] [Related]
6. Adoptive T Cell Therapies: A Comparison of T Cell Receptors and Chimeric Antigen Receptors.
Harris DT; Kranz DM
Trends Pharmacol Sci; 2016 Mar; 37(3):220-230. PubMed ID: 26705086
[TBL] [Abstract][Full Text] [Related]
7. T
Raffin C; Vo LT; Bluestone JA
Nat Rev Immunol; 2020 Mar; 20(3):158-172. PubMed ID: 31811270
[TBL] [Abstract][Full Text] [Related]
8. What does the future hold for cell-based tolerogenic therapy?
Bluestone JA; Thomson AW; Shevach EM; Weiner HL
Nat Rev Immunol; 2007 Aug; 7(8):650-4. PubMed ID: 17653127
[TBL] [Abstract][Full Text] [Related]
9. Therapy: HSCT-resetting immune tolerance by boosting TREG cell diversity.
Duarte JH
Nat Rev Rheumatol; 2015 Dec; 11(12):681. PubMed ID: 26526646
[No Abstract] [Full Text] [Related]
10. Chimeric antigen receptor transduced T cells: Tuning up for the next generation.
Schubert ML; Hoffmann JM; Dreger P; Müller-Tidow C; Schmitt M
Int J Cancer; 2018 May; 142(9):1738-1747. PubMed ID: 29119551
[TBL] [Abstract][Full Text] [Related]
11. Redirected T cells in cancer therapy.
Sangiolo D
Expert Opin Biol Ther; 2015; 15(12):1667-70. PubMed ID: 26515608
[TBL] [Abstract][Full Text] [Related]
12. Strategies to cure experimental autoimmune colitis using antigen-specific Foxp3+ regulatory T cells.
de Zoeten EF; Hancock WW
Gastroenterology; 2008 Jun; 134(7):2171-4. PubMed ID: 18482583
[No Abstract] [Full Text] [Related]
13. [Not Available].
Comte D
Rev Med Suisse; 2024 Jun; 20(877):1139. PubMed ID: 38836401
[No Abstract] [Full Text] [Related]
14. T cell subtypes and its therapeutic potential in autoimmune diseases and cancer.
Awasthi A; Kumar H
Int Rev Immunol; 2019; 38(5):181-182. PubMed ID: 31608783
[No Abstract] [Full Text] [Related]
15. CAR T Cell Therapy for Solid Tumors.
Newick K; O'Brien S; Moon E; Albelda SM
Annu Rev Med; 2017 Jan; 68():139-152. PubMed ID: 27860544
[TBL] [Abstract][Full Text] [Related]
16. [Immune cell therapy using iPS cells].
Yano H; Kaneko S
Rinsho Ketsueki; 2018; 59(2):225-231. PubMed ID: 29515078
[TBL] [Abstract][Full Text] [Related]
17. Antigenic targets of CAR T Cell Therapy. A retrospective view on clinical trials.
Arabi F; Torabi-Rahvar M; Shariati A; Ahmadbeigi N; Naderi M
Exp Cell Res; 2018 Aug; 369(1):1-10. PubMed ID: 29758187
[TBL] [Abstract][Full Text] [Related]
18. How antigen specificity directs regulatory T-cell function: self, foreign and engineered specificity.
Hoeppli RE; MacDonald KG; Levings MK; Cook L
HLA; 2016 Jul; 88(1-2):3-13. PubMed ID: 27256587
[TBL] [Abstract][Full Text] [Related]
19. Establishing guidelines for CAR-T cells: challenges and considerations.
Wang W; Qin DY; Zhang BL; Wei W; Wang YS; Wei YQ
Sci China Life Sci; 2016 Apr; 59(4):333-9. PubMed ID: 26965523
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans.
Roncarolo MG; Battaglia M
Nat Rev Immunol; 2007 Aug; 7(8):585-98. PubMed ID: 17653126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
